RapidAI Raised $75M Series C

California-based, RapidAI is a health tech AI designed to prevent life-threatening vascular, cardiac, and neurovascular diseases that raised $75 million led by Vista Credit Partners in a Series C round.

Vista Equity Partners subsidiary Vista Credit Partners led the round independently.

RapidAI AI-Powered $75M Series By Vista Credit

CEO RapidAI, Karim Karti said that the funds raised enable us to add more diseases to our platform and make our product a good fit for the market.

RapidAI is an AI platform that has complete care for stroke diseases. RapidAI working on Rapid NCCT Stroke (an FDA-approved medical device that detects ICH and LVO).

Rapid NCCT Stroke has imaging capabilities that a hospital can use to address wider health issues. Moreover, RapidAI is working on additional programs to diagnose other diseases early.

Also Read: Sekoia.io Raised €35M Series A

By Admin

Leave a Reply

Your email address will not be published. Required fields are marked *